Podcasts about Fabry

  • 183PODCASTS
  • 366EPISODES
  • 45mAVG DURATION
  • 1EPISODE EVERY OTHER WEEK
  • Mar 6, 2025LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about Fabry

Latest podcast episodes about Fabry

La Lanterna
Ep. 100 - Cento!!

La Lanterna

Play Episode Listen Later Mar 6, 2025 51:06


Matt and Fabry are back! This week's episode recaps how Genoa have fared thus far under Patrick Vieira. Plus, the gang preview il grifone's upcoming match against Cagliari

TOCSIN PODCAST
La Matinale Tocsin du 12/02 : Trump face à l'histoire ! Avec Phillipe Fabry

TOCSIN PODCAST

Play Episode Listen Later Feb 18, 2025 130:30


La matinale du 12 février présentée par Clémence Houdiakova, au sommaire aujourd'hui :2:30 Une plainte pénale déposée pour tromperie aggravée contre les différentes autorités de santé !

Proactive - Interviews for investors
Protalix BioTherapeutics Outlines Strategic Roadmap for 2025

Proactive - Interviews for investors

Play Episode Listen Later Jan 23, 2025 6:45


Protalix BioTherapeutics CEO Dror Bashan recently detailed the company's vision for 2025, highlighting advancements in its proprietary ProCellEx platform and its commitment to addressing unmet medical needs. Protalix specializes in producing complex human proteins using plant cell technology, focusing on therapies for Fabry and Gaucher diseases while exploring new opportunities in other therapeutic areas. A key achievement in 2024 was the successful completion of a Phase 1 clinical trial for the company's treatment candidate for gout. Positive trial results have set the stage for a Phase 2 study, scheduled to begin in mid-2025. Bashan also emphasized Protalix's robust financial position, with the company becoming debt-free as of September 2024—a milestone that supports ongoing operations, clinical trials, and pipeline expansion. Protalix is also actively working to extend the reach of Elfabrio, its FDA-approved therapy for Fabry disease. Additionally, the company is leveraging its innovative platform to explore next-generation solutions in renal and other therapeutic areas, aiming to broaden its impact on patient care. Looking ahead, Protalix plans to focus on addressing unmet needs in renal therapies while continuing to build on the success of its current treatments. With a strong financial foundation and a dedication to innovation, the company is well-positioned for transformative growth in 2025 and beyond.

Angry Mortgage
Feet On The Ground Mortgage News | Special Guest: Sacha Fabry | EP. 106

Angry Mortgage

Play Episode Listen Later Jan 21, 2025 50:12


Sometimes you must investigate what is going in the trenches of the mortgage business: what are borrowers saying, what they are they thinking. This week we have Sacha Fabry a Front-Line Mortgage Broker at our company who is fielding over 100 calls a week from mortgage borrowers. What kind of mortgage do they want, how bad are the renewal increases, is there really a mortgage rate WAR at the Banks? Why to NEVER trust the First Rate you are offered? Is it genuinely getting harder to get a mortgage? All this and more at Angry Mortgage.

Rare Disease Discussions
Optimizing Therapeutic Proteins Through PEGylation: Key Parameters and Impacts

Rare Disease Discussions

Play Episode Listen Later Jan 18, 2025 61:41


João GonçalvesFaculty of PharmacyUniversity of LisbonLisbon, PortugalPaolo CalicetiDepartment of Pharmaceutical and Pharmacological SciencesUniversity of PadovaPadova, ItalyWhat Is PEGylation and Why Is It Important?We will begin by examining the clinical uses of therapeutic proteins, and their applications in healthcare. Next, we will discuss the inherent limitations of therapeutic proteins, including challenges such as pharmacokinetic (PK) profiles, protein aggregation during storage, and potential immune responses. The session will then delve into the process of PEGylation, where polyethylene glycol (PEG) is conjugated to functional amino acid groups on the protein surface. This modification may enhance the properties of therapeutic proteins, offering advantages in stability, half-life, and immunogenicity.Biopharmaceutical and Immunological Properties of PEGylated ProteinsWe will explore the biopharmaceutical and immunological properties of PEGylated proteins, focusing on how their unique structure and composition impact their function. We will discuss how each PEGylated protein has distinct properties based on PEG architecture, molecular weight and degree of conjugation that cannot be generalized across different pegylated molecules, highlighting the variability in pharmacokinetic (PK) characteristics such as half-life, absorption, distribution, and elimination. These factors can significantly influence clinical outcomes, including dosing intervals and overall therapeutic effectiveness. We will also address the potential clinical advantages and limitations of PEGylation, with real-world examples to illustrate how these proteins are used in practice.Immunogenicity Considerations of PEGylated ProteinsWe will explore the immunogenicity of PEGylated proteins, examining both the potential benefits and risks associated with PEG modification. While PEGylation can trigger immune responses against PEG itself or the PEGylated protein, it can also help mask epitopes and reduce anti-drug antibodies formation. Drug- and patient-related factors that influence immunogenicity risk will also be covered, along with the prevalence and impact of pre-existing anti-drug antibodies (ADAs).We will discuss the potential clinical consequences of immune reactions to PEG or PEGylated proteins, and how the risk of such responses can vary depending on the unique properties of each PEGylated protein. The session will also address strategies to mitigate anti-PEG immunogenicity, as well as approaches for monitoring immunogenicity across different stages of drug development—from preclinical studies to post-marketing surveillance. Additionally, we will explore tools that may help predict therapeutic responses to PEGylated proteins, touching on potential areas for future research.Discussion and ConclusionBy the end of the session, participants will gain a comprehensive understanding of:How PEGylation represents a major technological advancement in the development and optimization of therapeutic proteins.How PEGylation affects both the biopharmaceutical properties and clinical applications of therapeutic proteinsImmunogenicity in the context of PEGylated proteins and the strategies used to manage and predict immune responses.The role of PEGylation in therapeutic outcomes and the future opportunities for innovation in this field.

Na place
Komentátor F1 Fabry: Sezona 2024 byla krásná. Očekávám, co Hamilton předvede v červeném v té další

Na place

Play Episode Listen Later Dec 18, 2024 35:53


Hostem středečního pořadu Na place s Davidem Novotným byl spolukomentátor závodů F1 Pavel Fabry. Jak ho bavila sezona 2024? Co očekává od Maxe Verstappena v následující sezoně a na co se mohou diváci těšit? Jak se po 26 letech zrodilo vítězství McLarenu v Poháru konstruktérů? Jak reálné je, aby se v seriálu F1 objevil někdo z Čechů? Poslechněte si celý rozhovor.Všechny díly podcastu Na place můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

TOCSIN PODCAST
La Matinale Tocsin du 10/12 : vers la fin de la Vème République ? Avec Philippe Fabry

TOCSIN PODCAST

Play Episode Listen Later Dec 10, 2024 124:33


La Lanterna
Ep. 99 - Vieira, Whoah!

La Lanterna

Play Episode Listen Later Nov 22, 2024 44:09


Matt and Fabry react to the sacking of Alberto Gilardino and appointment of Patrick Vieira as Genoa's new Mister.

La Lanterna
Ep. 98 - Super Mario

La Lanterna

Play Episode Listen Later Nov 15, 2024 53:59


Matt and Fabry react to Genoa's recent string of fixtures, discuss Balotelli's arrival, and tip their caps to the marketing of Genoa's third kit.

Hearing Matters Podcast
Intelligent Hearing: Dr. Dave Fabry on AI Advancements in Hearing Aids

Hearing Matters Podcast

Play Episode Listen Later Nov 13, 2024 47:37 Transcription Available


Send us a textJoin us for a fascinating conversation with Dr. David Fabry, Chief Hearing Health Officer at Starkey, as we explore the groundbreaking innovations in hearing aid technology. Discover how advancements in machine learning and deep neural networks are transforming these devices from manual tools into intelligent systems that automatically adjust to any acoustic environment, enhancing the user's auditory experience.Dr. Fabry takes us through an illuminating journey into the realm of artificial intelligence in audiology. By drawing parallels between a child's language acquisition and the learning process of deep neural networks, he vividly explains how these technologies have evolved to dramatically improve signal-to-noise ratios. We dive into the transition from traditional machine learning to modern DNN, highlighting how real-time processing and open real-time analysis are revolutionizing noise management by offering a fresh perspective on sound environments.In our final segment, we explore the significant role of AI in enriching hearing aid features, from binaural fusion to sound localization and the integration of voice assistants. With insights on the exponential growth of computational power and the pivotal role of apps like HearShare, we discuss how AI technologies foster user independence, safety, and improved quality of life. Tune in to uncover how these cutting-edge advancements are not only enhancing auditory perception but also redefining the future of hearing aids.While we know all hearing aids amplify sounds to help you hear them, Starkey Genesis AI uses cutting-edge technology designed to help you understand them, too.Click here to find a provider near you and test drive Starkey Genesis AI! Support the showConnect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Twitter: @hearing_mattasFacebook: Hearing Matters Podcast

Biotech Clubhouse
Episode 118

Biotech Clubhouse

Play Episode Listen Later Oct 30, 2024 61:28


On this episode of Biotech Hangout, hosts Chris Garabedian, Daphne Zohar, Josh Schimmer, Tim Opler, Paul Matteis and special guest Allison DeAngelis kick off the show with a look at the renewed interest and recent funding in the neuropsychiatric disease space, including Seaport Therapeutics' $225 million Series B financing. This progresses into a comparison of diversified versus focused pipelines as Roivant CEO Matt Gline joins the stage as an impromptu guest to share his perspective on the benefits and challenges of the hub-and-spoke model. The group also discusses recent biotech market performance and how the statistics show that biotech is actually having a really good year. Turning to data, the hosts cover Alto Neurosciences' Phase 2 results and discuss the idea of precision psych and the use of biomarkers in clinical trials. The group also discusses Vertex's Phase 2 pain data and how Intellia's positive Phase 2 data in hereditary angioedema moved the stock in the surprisingly wrong direction. Other topics discussed include Sangamo's accelerated path for its Fabry gene therapy, Starboard takes on Pfizer, Alkermes and Roche earnings highlights, and more. *This episode aired on October 25, 2024.

The Andrew Carter Podcast
The Andrew Carter Morning Show (Friday October 25, 2024)

The Andrew Carter Podcast

Play Episode Listen Later Oct 25, 2024 46:21


Carolyn Baglole, Trudie Mason, Craig Ferguson, John Moore, Tom Mulcair, Dr. Mitch Shulman, Frédéric Fabry, Chris Bumbray

The Andrew Carter Podcast
Montreal receives a third less snow since 1863

The Andrew Carter Podcast

Play Episode Listen Later Oct 25, 2024 6:30


Montreal winters have lost a third of its snow since the mid 19th century according to an analysis of decades of meteorological data compiled by McGill University. The numbers have only been recently discovered with the help of a weather archive rescue project developed in 2018 as all of the data was collected by hand during that era. Frédéric Fabry is head of McGill's Bieler School of the Environment, he spoke to Andrew Carter.

La Lanterna
Ep. 97 - It's Gonna Take Balls

La Lanterna

Play Episode Listen Later Oct 18, 2024 53:47


Matt and Fabry recap Genoa's current situation with the 5-1 loss against Atalanta and look forward to a come back at the weekend's match against Bologna

IIEA Talks
Elvire Fabry, Martin Sandbu, Sander Tordoir 'The end of the free market and free trade in Europe?'

IIEA Talks

Play Episode Listen Later Oct 17, 2024 47:36


'The end of the free market and free trade in Europe?' The recent imposition of tariffs on Chinese electric vehicles by the EU, which won the support of member states including Ireland, is just one illustration of how the potential downsides of free trade have been given greater prioritisation in Europe in recent years. The appointment of a European Commissioner for Trade and Economic Security for the first time underscores a fundamental rethinking of core EU competences such as competition policy, state aids, and trade. Elvire Fabry, Martin Sandbu, and Sander Tordoir will discuss the origins of this rethink and how it will shape future policy outcomes in the EU. Elvire Fabry is Senior Research Fellow at the Jacques Delors Institute, in charge of the geopolitics of trade and rapporteur of the working group on EU-China relations. Her areas of expertise include EU bilateral trade negotiations, EU-US relations, EU-China relations, investment, global governance, WTO reform, Brexit, and perceptions of globalisation. Martin Sandbu is the European Economics Commentator at the Financial Times where he writes on a range of international affairs issues drawing insight from the intersection of economics, politics, and ethics. He is the also the author of a number of books, including The Economics of Belonging: A Radical Plan to Win Back the Left-Behind and Achieve Prosperity for All. Before joining the Financial Times, he worked in policy consulting and academia, including at Harvard, Columbia, and the Wharton School. Sander Tordoir is Chief Economist at the Centre for European Reform where he works on eurozone monetary and fiscal policy and the institutional architecture of EMU and European integration. Prior to joining the CER, he worked at the ECB in Frankfurt, as advisor to the ECB Representative at the International Monetary Fund in Washington DC and at the German Federal Finance Ministry.

La Lanterna
Ep. 96 - At the crosswords

La Lanterna

Play Episode Listen Later Oct 4, 2024 122:35


Matt and Fabry react to Genoa's bad run of form and look at options Gila has to turn the campaign around.

Blog Deportivo
Fabry Castro sobre gol contra Nacional: "Nos permite volver a soñar"

Blog Deportivo

Play Episode Listen Later Sep 24, 2024 7:33


El actual campeón consiguió su cuarta victoria en la liga y volvió a acercarse al grupo de los ocho. La pelota quieta puso a celebrar a miles de leopardos.See omnystudio.com/listener for privacy information.

Stuff You Missed in History Class
Charlotte Cooper Sterry, Tennis Champion

Stuff You Missed in History Class

Play Episode Listen Later Sep 2, 2024 34:42 Transcription Available


Charlotte Cooper Sterry was a tennis player who set records during her lifetime that remained unbroken for almost a century. One of them still stands. Research: Yang, Heewon, and Kelly Chandler. "Tennis." Encyclopedia of Recreation and Leisure in America, edited by Gary S. Cross, vol. 2, Charles Scribner's Sons, 2004, pp. 351-354. Gale In Context: U.S. History, link.gale.com/apps/doc/CX3434800256/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=64f7cfa9. Accessed 15 July 2024. com. “The Oldest' Ladies Champions.” 9/29/2017. https://www.wimbledon.com/en_GB/news/articles/2017-09-29/2017-09-29_2017-09-29_the_oldest_ladies_singles_champions.html Bennett, Courtney. "Wimbledon." St. James Encyclopedia of Popular Culture Online, Gale, 2013. Gale In Context: U.S. History, link.gale.com/apps/doc/PUXWIE130945815/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=8c49dec7. Accessed 15 July 2024. Reilley, Lucas. “Tennis: The Sport that Loves to Kill Royalty.” 10/12/2018. https://www.mentalfloss.com/article/560200/tennis-related-royal-deaths "Tennis." Britannica Library, Encyclopædia Britannica, 25 Mar. 2024. libraries.state.ma.us/login?eburl=https%3A%2F%2Flibrary.eb.com&ebtarget=%2Flevels%2Freferencecenter%2Farticle%2Ftennis%2F108495&ebboatid=9265899. Accessed 15 Jul. 2024. Fabry, Merrill. “Why Is Tennis Scored So Weirdly?” Time. 7/14/2023. https://time.com/5040182/tennis-scoring-system-history/ “Wingfield and the birth of lawn tennis.” 5/15/2024. https://www.wimbledon.com/en_GB/news/articles/2024-05-15/wingfield_and_the_birth_of_lawn_tennis.html Smyth, J. G. "Sterry [née Cooper], Charlotte Reinagle (1870–1966), tennis player." Oxford Dictionary of National Biography. October 04, 2012. Oxford University Press. Date of access 15 Jul. 2024, https://www-oxforddnb-com.proxy.bostonathenaeum.org/view/10.1093/ref:odnb/9780198614128.001.0001/odnb-9780198614128-e-36284 Chambers, Mrs. Lambert. “Lawn Tennis for Ladies.” New York. Outing Publishing Company. 1910. https://archive.org/details/lawntennisforla00chamgoog/ Team GB. “Charlotte Cooper: The original trailblazer of women's tennis.” 3/7/2021. https://www.teamgb.com/article/charlotte-cooper-the-original-trailblazer-of-womens-tennis/PFWDdf3Zq306yiPqsw6VA1 Little, Alan. “Wimbledon Ladies : a centenary record 1884-1984 : the Single champions.” London : Wimbledon Lawn Tennis Museum. 1984. https://archive.org/details/wimbledonladiesc0000litt/ Myers, Arthur Wallis. “Lawn Tennis at Home and Abroad.” Scribner's. 1903. https://archive.org/details/lawntennisathom00myergoog/ Hillyard, George Whiteside. “Forty Years of First-class Lawn Tennis.” Williams & Norgate. 1924. https://books.google.com/books?id=lHtYAAAAYAAJ Weaver, Harry. “'Chattie' the Champion.” The London Observer. 6/27/1965. https://www.newspapers.com/image/258000462/ Robyns, Gwen. “Wimbledon; the hidden drama.” Newton Abbot, David & Charles. 1973. Troy Lennon History Editor. "First woman Olympic tennis champ was deaf". The Daily Telegraph (Australia), September 22, 2020 Tuesday. advance-lexis-com.proxy.bostonathenaeum.org/api/document?collection=news&id=urn:contentItem:60WR-RPC1-F0JP-W1PJ-00000-00&context=1519360. Accessed July 16, 2024. Robertson, Max. “Wimbledon 1877-1977.” London : Barker. 1977. See omnystudio.com/listener for privacy information.

Heart podcast
What are the predictors of Fabry's disease progression despite enzyme therapy?

Heart podcast

Play Episode Listen Later Aug 27, 2024 16:51


In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Niccolo Maurizi from Lausanne, Switzerland. They discuss his recent paper in Heart on a Swiss Fabry's regsitry. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 or wherever you get your podcasts - it's really helpful. Link to published paper: https://heart.bmj.com/content/early/2024/05/15/heartjnl-2024-323975

La Lanterna
Ep. 94 - Gallinaccio

La Lanterna

Play Episode Listen Later Aug 22, 2024 62:06


Matt and Fabry recap Genoa's 2-2 draw against Inter and look forward to the weekend's match against Monza

La Lanterna
Ep. 94 - Excuse us for our Brief Absence

La Lanterna

Play Episode Listen Later Aug 14, 2024 60:56


We're back! Matt and Fabry break down Genoa's transfer market thus far and look ahead to the first match of the season against Inter.

Starkey Sound Bites
A Deep Dive into Starkey's Industry-leading AI Hearing Technology

Starkey Sound Bites

Play Episode Listen Later Aug 7, 2024 37:13


In this episode, we turn the tables on our host, Dave Fabry. For the first time, Dr. Fabry finds himself on the other side of the Sound Bites microphone, to take our listeners on a deep dive into Starkey's industry-leading hearing technology. From artificial intelligence (AI) to deep neural networks (DNN), learn how this technology is making life better for patients and how hearing professionals can take small steps toward implementing it into their practices. Hearing Matters host Doug Beck guest hosts this special episode of Sound Bites. To learn more about the latest in Starkey's hearing technology, visit starkeypro.com Link to full transcript.

Educational AD Podcast
Candice Fabry - Wednesday Wisdom #127

Educational AD Podcast

Play Episode Listen Later Jul 10, 2024 16:42


Candice Fabry, the Head Women's Soccer Coach at Ottawa University in Kansas is BACK on Wednesday Wisdom and today she shares the Connection between Motivation and Commitment! Candice is also the Founder of Fearless and Capable - a Women led Mentoring and Coaching platform. THIS is The Educational AD Podcast! --- Support this podcast: https://podcasters.spotify.com/pod/show/educational-ad-podcast/support

The Boardroom Buzz Pest Control Podcast
Episode 175 — Lessons in Culture & Authenticity with Caleb Fabry

The Boardroom Buzz Pest Control Podcast

Play Episode Listen Later Jun 13, 2024 84:49


In this episode, we spoke with Caleb Fabry, owner of Town & Country Pest Solutions in Rochester, New York. Caleb discusses the importance of a strong company culture and employee engagement. By using the Culture Index, he aligns team members with roles that fit their unique attributes while enhancing communication. How can utilizing culture tools help to retain team members, create mission alignment, and beat your financial goals? A significant part of Caleb's marketing strategy involves a dedicated in-house team focused on video content and social media. This approach has helped Town & Country Pest Solutions build a strong online presence and engage effectively with customers. How might investing in professional video content and social media marketing benefit your business? Learning from peer business owners has been crucial for Caleb's success. Joining leadership groups has provided valuable insights and the confidence to implement new ideas. Caleb has embraced the word "yes" when it comes to new opportunities, even outside his comfort zone. Who is pushing you to reach new heights and implement new strategies?

Rare Disease Discussions
Fabry Disease Overview, Featuring William Burns, MD

Rare Disease Discussions

Play Episode Listen Later Jun 8, 2024 24:28


In this first part of our four-part series on Fabry disease, we feature William Burns, MD, a biochemical geneticist at Greenwood Genetic Center in Greenwood, South Carolina. Dr. Burns summarizes this rare disease, including current management strategies.Fabry disease is a lysosomal storage disorder, meaning that a glycosphingolipid called GL-3 accumulates in the lysosomes, causing tissue damage; many cell types are affected.The disease is caused by mutations in the GLA gene, resulting in nonfunctional or dysfunctional alpha-galactosidase A, a lysosomal enzyme. The mutations can be inherited, so multiple family members can have the disease.Fabry disease is a multisystemic disease, affecting many organs, including the heart, kidney and nervous system, resulting in life-threatening complications and a reduced life expectancy. Early signs of the disease start in childhood and adolescence, but it is a progressive, lifelong condition.Newborn screening has now been performed in several countries, yielding a prevalence ranging from 1 in 1,368 to 1 in 8,882 births.

Rare Disease Discussions
Fabry Disease From a Patient's Perspective, Featuring Maya Kineen

Rare Disease Discussions

Play Episode Listen Later Jun 8, 2024 15:14


In this episode of our series focused on Fabry disease, we feature Maya Kineen, a patient and advocate with this rare disorder.Fabry disease is an inherited disorder that results from the buildup of a particular type of fat, called globotriaosylceramide, in the body's cells. Beginning in childhood, this buildup causes signs and symptoms that affect many parts of the body. Characteristic features of Fabry disease include episodes of pain, particularly in the hands and feet (acroparesthesias); clusters of small, dark red spots on the skin called angiokeratomas; a decreased ability to sweat (hypohidrosis); cloudiness of the front part of the eye (corneal opacity); problems with the gastrointestinal system; ringing in the ears (tinnitus); and hearing loss. Fabry disease also involves potentially life-threatening complications such as progressive kidney damage, heart attack, and stroke. Some affected individuals have milder forms of the disorder that appear later in life and affect only the heart or kidneys.

Rare Disease Discussions
Signs and Symptoms of Fabry Disease, Featuring Nicola Longo, MD

Rare Disease Discussions

Play Episode Listen Later Jun 8, 2024 24:35


This is the second of a three-part series focusing on Fabry disease. In this episode, we talk with Nicola Longo, MD, Chief of the Division of Medical Genetics at the University of Utah, Spencer Fox Eccles School of Medicine in Salt Lake City. Dr. Longo discusses Fabry disease, including the progression of the disease and personalized medicine.Fabry disease is an inherited disorder that results from the buildup of globotriaosylceramide or GL-3. The disorder affects many parts of the body. Signs and symptoms may include acroparesthesias, angiokeratomas, hypohidrosis, corneal opacity, and hearing loss. Potentially severe complications can include progressive kidney damage, heart attack, and stroke. Fabry disease is caused by mutations in the GLA gene and is inherited in an X-linked manner. Treatment may include enzyme replacement therapy (ERT); pain medications, ACE inhibitors; and chronic hemodialysis or renal transplantation for end stage renal disease.

Critical Care Scenarios
Episode 75: Automatic tube compensation, with Ben Fabry

Critical Care Scenarios

Play Episode Listen Later May 29, 2024 56:54


We discuss the principles and application of automatic tube compensation (ATC) on modern ventilators, with its creator Ben Fabry. Dr. Fabry is a professor and chair of biophysics at University of Erlangen-Nuremberg, originally trained as an electrical engineer, who originally developed ATC as part of his PhD program. Find us on Patreon here! Buy your … Continue reading "Episode 75: Automatic tube compensation, with Ben Fabry"

La Lanterna
Ep. 93 - A New Baby Genoano

La Lanterna

Play Episode Listen Later May 17, 2024 30:39


Matt and Fabry recap Genoa's a conformable win 3-0 against Cagliari, thrilling tie against Milan and important win 2-1 against Sassuolo, and preview Roma-Genoa for the second last match of the season.

RARECast
Using Directed Evolution to Develop New Vectors for Genetic Medicines

RARECast

Play Episode Listen Later May 2, 2024 31:08


Much of the challenge of developing genetic medicines lies in having the right vector to deliver the therapy to the cells within the body where they need to go. 4D Molecular Therapeutics has developed platform technology that generates large numbers of genetically diverse, synthetic adeno-associated viral vectors that have desired characteristics using a process known as directed evolution. It is using these vectors to build a pipeline of genetic medicines across a broad set of conditions. We spoke to Alan Cohen, senior vice president of clinical development and therapeutic area head of pulmonology for 4DMT, about the limitations of existing vectors for genetic medicines, 4DMT's directed evolution platform technology, and its programs in cystic fibrosis and Fabry disease.

Remember The Girls
Episode 48: Fabry Disease with Taylor & Andrea

Remember The Girls

Play Episode Listen Later Apr 30, 2024 33:43


*SOLIDARITY EPISODE* This month in partnership with ⁠Fabry Support & Information Group⁠! Our Carrier Connections program features a different X-linked condition each month with the goal to increase awareness of X-linked conditions and how they impact the lives of women and girls. This month, we are featuring Fabry disease. Fabry Disease is a rare X-linked disorder caused by a mutation in the gene encoding for the α-galactosidase A (α-Gal A) enzyme, or GLA gene, which typically functions to produce a protein required for the breakdown of lipids in cells. Females tend to have a variable course of Fabry disease with some experiencing severe symptoms while others experience less severe symptoms than males or none at all. However, recent research has determined that the most common symptoms in females affected by Fabry disease are neuropathic pain, angiokeratoma (clusters of small, dark red spots), proteinuria (high levels of protein in urine), buildup in the cornea of the eyes, and cardiac disease. Additionally, 10% of females experience renal failure and need dialysis. Depression is also reported to be another manifestation of Fabry disease with 22% of females experiencing depressive symptoms. Aside from these manifestations, more recent research has discovered females with Fabry disease tend to experience: exhaustion, exercise intolerance, decreased oxygen intake, gastroenterological disturbances, infertility, loss of libido, increased risk of headaches, and severity of Fabry-related symptoms in pregnancy. Today, we are bringing on Taylor and her mother, Andrea. Taylor is a young adult living with Fabry disease. She and Andrea discuss the challenges they faced getting Taylor's symptoms taken seriously, how their family supports Taylor through the trials and tribulations brought about by Fabry, and why they advocate. Find them here: Taylor's Instagram - @_friendswithfabry_ Andrea's email - andiemick@aol.com Carrier Connections is sponsored by Kyowa Kirin and Amgen. For more information about our organization, check out ⁠⁠⁠⁠⁠⁠⁠⁠⁠rememberthegirls.org⁠⁠⁠⁠⁠⁠⁠⁠⁠.

depression disease females amgen gla fabry information group kyowa kirin
La Lanterna
Ep. 92 - Genova is Genoa

La Lanterna

Play Episode Listen Later Apr 25, 2024 58:59


Matt and Fabry recap Genoa's narrow 1-0 loss to Lazio, recount Blazquez's recent comments on the club's future, react to the latest kit releases, and preview Genoa - Cagliari.

La Lanterna
Ep. 91 - La Viola-ted

La Lanterna

Play Episode Listen Later Apr 19, 2024 30:25


Matt and Fabry breakdown Genoa's 1-1 draw against Fiorentina including some questionable referee decisions and look ahead to the upcoming home match against Lazio.

Remember The Girls
Fabry Disease with with Lisa Berry, LGC

Remember The Girls

Play Episode Listen Later Apr 12, 2024 18:39


This month in partnership with ⁠⁠Fabry Support & Information Group! This month, we are featuring Fabry disease. Fabry Disease is a rare X-linked disorder caused by a mutation in the gene encoding for the α-galactosidase A (α-Gal A) enzyme, or GLA gene, which typically functions to produce a protein required for the breakdown of lipids in cells. Females tend to have a variable course of Fabry disease with some experiencing severe symptoms while others experience less severe symptoms than males or none at all. However, recent research has determined that the most common symptoms in females affected by Fabry disease are neuropathic pain, angiokeratoma (clusters of small, dark red spots), proteinuria (high levels of protein in urine), buildup in the cornea of the eyes, and cardiac disease. Additionally, 10% of females experience renal failure and need dialysis. Depression is also reported to be another manifestation of Fabry disease with 22% of females experiencing depressive symptoms. Aside from these manifestations, more recent research has discovered females with Fabry disease tend to experience: exhaustion, exercise intolerance, decreased oxygen intake, gastroenterological disturbances, infertility, loss of libido, increased risk of headaches, and severity of Fabry-related symptoms in pregnancy. Today, we are bringing on Lisa Berry. Lisa Berry graduated from the Brandeis University Genetic Counseling program in Waltham, MA. She has worked as a prenatal counselor in New York City, a lab coordinator for Genzyme Genetics and a study coordinator at Tufts/New England Medical Center. In 2008, she became a genetic counselor with the Rare Genetic Disease Program at Cincinnati Children's Hospital. It was here that she was able to start working with individuals and families whose lives have been impacted by lysosomal storage disorders. In addition to providing genetic counseling for families, she is on the Ohio Newborn Screening Advisory Council and is a member of the Board of Directors for the National MPS Society. Her main roles are treatment/care coordination, advocacy and working on clinical trials for various LSDs. Carrier Connections is sponsored by Kyowa Kirin and Amgen. For more information about our organization, check out ⁠⁠⁠⁠⁠⁠⁠⁠rememberthegirls.org⁠⁠⁠⁠⁠⁠⁠⁠.

La Lanterna
Ep. 90 - Battle vs la Viola - Special Guest Gabriele Pucci

La Lanterna

Play Episode Listen Later Apr 12, 2024 67:11


Matt and Fabry recap Genoa's win against Verona and are joined by Gabriele "Gabe" Pucci to preview Monday's match against Fiorentina.

Remember The Girls
Episode 47: Fabry Disease with Sabina

Remember The Girls

Play Episode Listen Later Apr 9, 2024 33:30


*SOLIDARITY EPISODE* This month in partnership with Fabry Support & Information Group! Our Carrier Connections program features a different X-linked condition each month with the goal to increase awareness of X-linked conditions and how they impact the lives of women and girls. This month, we are featuring Fabry disease. Fabry Disease is a rare X-linked disorder caused by a mutation in the gene encoding for the α-galactosidase A (α-Gal A) enzyme, or GLA gene, which typically functions to produce a protein required for the breakdown of lipids in cells. Females tend to have a variable course of Fabry disease with some experiencing severe symptoms while others experience less severe symptoms than males or none at all. However, recent research has determined that the most common symptoms in females affected by Fabry disease are neuropathic pain, angiokeratoma (clusters of small, dark red spots), proteinuria (high levels of protein in urine), buildup in the cornea of the eyes, and cardiac disease. Additionally, 10% of females experience renal failure and need dialysis. Depression is also reported to be another manifestation of Fabry disease with 22% of females experiencing depressive symptoms. Aside from these manifestations, more recent research has discovered females with Fabry disease tend to experience: exhaustion, exercise intolerance, decreased oxygen intake, gastroenterological disturbances, infertility, loss of libido, increased risk of headaches, and severity of Fabry-related symptoms in pregnancy. Today, we are bringing on Sabina Kineen. Sabina is a rare disease patient, caregiver, and advocate with a deep passion for health equity, mental health, and patient engagement. Diagnosed with Fabry Disease in her teens, she has spent many years sharing how the diagnosis of an inherited disease can impact an entire family.  Sabina is also a strong proponent of health equity and strives to ensure that every patient has access to the care they need and deserve. Through her advocacy work, Sabina aims to raise awareness, promote understanding, and create meaningful change for rare disease patients and their families.  Carrier Connections is sponsored by Kyowa Kirin and Amgen. For more information about our organization, check out ⁠⁠⁠⁠⁠⁠⁠⁠rememberthegirls.org⁠⁠⁠⁠⁠⁠⁠⁠.

La Lanterna
Ep. 89 - He's Our Mister

La Lanterna

Play Episode Listen Later Apr 5, 2024 39:43


Matt and Fabry react to Genoa's draw vs Frosinone, the "mugugno" around Gila, and preview Genoa - Verona.

La Lanterna
Ep. 88 - Facing the Ciociari - Special guest Ferdinando (Kicking Cleats)

La Lanterna

Play Episode Listen Later Mar 29, 2024 61:11


Matt and Fabry recap Retegui's trip to the US with the Italian national team, react to the recently launched 4th kit, and are joined by Ferdinando of Kicking Cleats to preview Genoa - Frosinone

La Lanterna
Ep. 87 - We've got our stripes

La Lanterna

Play Episode Listen Later Mar 22, 2024 34:45


Matt and Fabry break down Genoa's hard fought draw away to Juventus just before the upcoming International Break

Rare Disease Discussions
Kidney Involvement in Lysosomal Disorders

Rare Disease Discussions

Play Episode Listen Later Mar 5, 2024 60:00


Ozlem Goker-Alpan, MD, Founder and President, LDRTC and David G. Warnock, MD. Professor of Medicine (Emeritus) at University of Alabama at Birmingham discuss best practices to identify and treat kidney problems associated with lysosomal disorders.This CME/CE activity describes the pathophysiologies and management options for lysosomal disease patients with kidney problems. This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees. To receive credit for this program, go to https://checkrare.com/learning/ Speakers Ozlem Goker-Alpan, MD, Founder and President, LDRTC David G. Warnock, MD. Professor of Medicine (Emeritus)University of Alabama at BirminghamDisclosuresAffinityCE staff, LDRTC staff, CheckRare staff, planners, and reviewers, have no relevant financial interests to disclose. All faculty disclosures are listed below and are included in the beginning of each presentation.Dr. Goker-Alpan is a consultant, a principal investigator and /or on the speaker bureau, or has received grant support, from the following pharmaceutical companies: Actelion, Amicus Therapeutics, Sanofi, Takeda, Pfizer/Protalix.Dr. Warnock has had research support and/or consulting arrangements with Genzyme Corporation (Sanofi), Shire LLC (Takeda), Amicus, Protalix and Chiesi, Zebra Bio, Walking Fish, Hanmi, and Vera Therapeutics.Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Learning ObjectivesAt the end of this activity, participants should be able to:Describe the role of the nephrologist in the team approach to careDescribe best practices to monitor kidney function in lysosomal disordersDescribe best practices to treat kidney disorders lysosomal disordersSupport for this educational activity was provided by Takeda, Sanofi, Amicus Therapeutics and Chiesi USA.

Cartoonist Kayfabe
Gaiman's SANDMAN Endless Dream Team: Russell, Manara, Quitely, Prado, Sienkiewicz, Storey, Fabry

Cartoonist Kayfabe

Play Episode Listen Later Jan 6, 2024 31:18


Beat the Kayfabe Effect at our Patreon: https://patreon.com/cartoonistkayfabe Ed's Links (Order RED ROOM!, Patreon, etc): https://linktr.ee/edpiskor Jim's Links (Patreon, Store, social media): https://linktr.ee/jimrugg ------------------------- E-NEWSLETTER: Keep up with all things Cartoonist Kayfabe through our newsletter! News, appearances, special offers, and more - signup here for free: https://cartoonistkayfabe.substack.com/ --------------------- SNAIL MAIL! Cartoonist Kayfabe, PO Box 3071, Munhall, Pa 15120 --------------------- T-SHIRTS and MERCH: https://shop.spreadshirt.com/cartoonist-kayfabe --------------------- Connect with us: Instagram: https://www.instagram.com/cartoonist.kayfabe/ Twitter: https://twitter.com/CartoonKayfabe Facebook: https://www.facebook.com/Cartoonist.Kayfabe Ed's Contact info: https://Patreon.com/edpiskor https://www.instagram.com/ed_piskor https://www.twitter.com/edpiskor https://www.amazon.com/Ed-Piskor/e/B00LDURW7A/ref=dp_byline_cont_book_1 Jim's contact info: https://www.patreon.com/jimrugg https://www.jimrugg.com/shop https://www.instagram.com/jimruggart https://www.twitter.com/jimruggart https://www.amazon.com/Jim-Rugg/e/B0034Q8PH2/ref=sr_tc_2_0?qid=1543440388&sr=1-2-ent

Taste Radio
Will Target's ‘Dry' Bet Pay Off? Plus, A Convo With CraftCo.

Taste Radio

Play Episode Listen Later Jan 5, 2024 48:43


When Target embraces emerging categories, we take notice. The hosts discussed the retailer's new curated endcaps of non-alcoholic cocktails and wine and what it means for the nascent set of zero-proof beverages. They also spoke about why Nosh is broadening its coverage (and tapped a new leader to helm the vertical) and how a fast-growing hydration brand and popular sparkling water company have each taken a bigger-is-better approach to their packaging,  This episode also features an interview with Will Fabry, the master distiller for CraftCo, a Michigan-based portfolio company that owns several acclaimed spirit brands, including  Jos. A. Magnus and Fox & Oden. Fabry spoke about CraftCo's distilling philosophy, how it operates at the intersection of production, consumer demand and pricing, and how he attempts to improve upon and become more proficient in his role. Show notes: 0:40: More Green Juice & THC. LinkedIn Loves Monica. A ‘Perfect' Upgrade. Kids + Tuna… Hmmm. – The hosts shared their thoughts on healthy habits for 2024 and chatted about Nosh's expanded lens and the warm reception online for its new managing editor, Monica Watrous. They also spoke about Lemon Perfect's move to a larger bottle and Spindrift's similar shift, why they're not convinced that a tuna company's attempt to woo kids will work and a sports drink brand's new line of better-you-sodas. 28:24: Interview: Will Fabry, Master Distiller, CraftCo – A 20-plus year veteran of the culinary industry, Fabry joined CraftCo in 2018. In our conversation, he spoke about the impact of Michigan's climate in how the company's spirits are finished, how he and his team are consistently meeting the high expectations that consumers have come to expect from CraftCo brands, and how he managed Covid-driven supply chain challenges. Brands in this episode: Trader Joe's, Evolution Fresh, Pressed Juicery, Biena, The Good Crisp, Lesser Evil, Lemon Perfect, Spindrift, De Soi, Ghia, Kin Euphorics, Surely, Nooma, Coppercraft, Jos. A. Magnus, Fox & Oden

Future Ear Radio
120 - Dave Fabry, Ph.D. - An Optimistic Viewpoint on the Future of Hearing Healthcare

Future Ear Radio

Play Episode Listen Later Jan 2, 2024 73:24


Guest: Dave Fabry, Ph.D. - Chief Hearing Health Officer at Starkey Dr. Fabry sits down with Dave this week to discuss: - His start as an aspiring Veterinarian, which ultimately exposed him to Audiology (training Chinchillas to "perform" an audiogram) - Dave's PhD, time at Walter Reed Army Medical Center, and Clinical Fellowship at The Mayo Clinic - The ACHIEVE study and Dave's big takeaways as both a clinician and researcher - The emerging use cases for biometric and acoustical data sets that are being captured and logged by Starkey's latest hearing aids - The evolution from machine learning-based applications to deep neural-net based applications for hearing aids - The case for why this is the most exciting time for Audiologists and Hearing Professionals broadly speaking, even with the existing and forthcoming challenges on the horizon - Career advice and words of wisdom from Dr. Fabry --- Send in a voice message: https://podcasters.spotify.com/pod/show/futureear/message

THE HUGE SHOW
The Huge Show - Coppercraft Interview - Will Fabry 12-22-23

THE HUGE SHOW

Play Episode Listen Later Dec 22, 2023 6:27


We were joined by Will Fabry who is a Distiller for Coppercraft. He talked to us about what makes Coppercraft different, talked about their culture, and more. See omnystudio.com/listener for privacy information.

Educational AD Podcast
Wednesday Wisdom #98 - Candice Fabry, Fearless & Capable

Educational AD Podcast

Play Episode Listen Later Dec 20, 2023 21:15


Candice Fabry is BACK on Wednesday Wisdom to help us close out the year and she shares some great advice on how to wrap up 2023 and make sure you get a Great start on 2024! This is The Educational AD Podcast! --- Send in a voice message: https://podcasters.spotify.com/pod/show/educational-ad-podcast/message Support this podcast: https://podcasters.spotify.com/pod/show/educational-ad-podcast/support

Cardionerds
349. Case Report: Into the Thick of It – An Unusual Cause of Hypertrophic Cardiomyopathy – Cleveland Clinic

Cardionerds

Play Episode Listen Later Dec 17, 2023 50:05


CardioNerds cofounder Dr. Amit Goyal and cardiology fellows from the Cleveland Clinic (Drs. Alejandro Duran Crane, Gary Parizher, and Simrat Kaur) discuss the following case: A 61-year-old man presented with symptoms of heart failure and left ventricular hypertrophy. He was given a diagnosis of obstructive hypertrophic cardiomyopathy. He eventually underwent septal myectomy, mitral valve replacement, aortic aneurysm repair, and aortic valve replacement with findings of Fabry's disease on surgical pathology. The case discussion focuses on the differential diagnosis for LVH and covers Fabry disease as an HCM mimic. Expert commentary was provided by Dr. Angelika Ewrin. The episode audio was edited by student Dr. Diane Masket. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media - An Unusual Cause of Hypertrophic Cardiomyopathy – Cleveland Clinic Pearls - An Unusual Cause of Hypertrophic Cardiomyopathy – Cleveland Clinic Left ventricular hypertrophy is a cardiac manifestation of several different systemic and cardiac processes, and its etiology should be clarified to avoid missed diagnosis and treatment opportunities. Fabry disease is a rare, X-linked inherited disease that can present cardiac and extra-cardiac manifestations, the former of which include hypertrophic cardiomyopathy, conduction defects, coronary artery disease, conduction abnormalities, arrhythmias, and heart failure.  The diagnosis of Fabry disease includes measurement of alpha-galactosidase enzyme activity as well as genetic testing to evaluate for pathogenic variants or variants of unknown significance in the GLA gene. Family members of patients diagnosed with Fabry disease should be screened based on the inheritance pattern.   Multimodality imaging can be helpful in the diagnosis of Fabry disease. Echocardiography can show left ventricular hypertrophy (LVH), reduced global strain, aortic and mitral valve thickening, and aortic root dilation with associated mild to moderate aortic regurgitation. Cardiac MRI can show hypertrophy of papillary muscles, mid-wall late gadolinium enhancement and low-native T1 signal.   The treatment of Fabry disease involves a multi-disciplinary approach with geneticists, nephrologists, cardiologists, nephrologists, and primary care doctors. Enzyme replacement therapy can delay the progression of cardiac disease.    Show Notes - An Unusual Cause of Hypertrophic Cardiomyopathy – Cleveland Clinic What are the causes of left ventricular hypertrophy? LVH is extremely common. It is present in 15-20% of the general population, and is more common in Black individuals, the elderly, obese or hypertensive individuals, with most cases being secondary to hypertension and aortic valve stenosis. In general terms, it is helpful to divide the causes of LVH into three main groups: high afterload states, obstruction to LV ejection, and intrinsic myocardial problems. Increased afterload states include both primary and secondary hypertension and renal artery stenosis. Mechanical obstruction includes aortic stenosis, subaortic stenosis, and coarctation of the aorta. Lastly, several intrinsic problems of the myocardium can cause LV hypertrophy, such as athletic heart with physiological LVH, hypertrophic cardiomyopathy with or without outflow obstruction, and infiltrative or storage diseases such as cardiac amyloidosis, Fabry's disease, or Danon disease, among others.  How does Fabry disease present? Fabry disease is present in all races and is an X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that result in reduced alpha-galactosidase enzyme activity,

Golden Ticket Podcast
Episode 2 - ATTENTION & It's Impact (ft. Olivia Fabry)

Golden Ticket Podcast

Play Episode Listen Later Nov 7, 2023 65:01


Welcome back to the Golden Ticket! In this episode... Jimmy, Reese, and Isaiah are joined by University of Notre Dame pole vaulter Olivia Fabry, who has also grown a large following on social media. We were able to talk to her about how she deals with the attention on and off the track, and how it has changed her life. Thank you all for listening. Enjoy! We are proud to provide you with your... GOLDEN TICKET

Structure Talk
Regional Inspection Differences (with Chad Fabry)

Structure Talk

Play Episode Listen Later Nov 6, 2023 50:09 Transcription Available


In today's episode, Reuben Saltzman and Tessa Murry are joined by Chad Fabry from StructureSmart. The discussion focuses on the unique challenges and characteristics of home inspections in Western New York, particularly in areas with historic homes dating back to the 1700s and 1800s. Chad Fabry shares his expertise in dealing with older houses, highlighting issues related to basements, and crawl spaces, and finishing these spaces. The importance of understanding building science and relying on reliable sources of information for home inspections is emphasized. Chad also discusses his role in teaching continuing education classes for home inspectors in New York. The conversation provides valuable insights for both home inspectors and homeowners dealing with older homes and regional differences in home inspections.

JACC Podcast
Prognostic Implications of the Extent of Cardiac Damage in Patients with Fabry Disease

JACC Podcast

Play Episode Listen Later Oct 2, 2023 10:02


Healthful Woman Podcast
“Advanced Level Carrier Screening: Some things we might learn about the mother” – with Dr. Goldwaser

Healthful Woman Podcast

Play Episode Listen Later Jun 26, 2023 33:02


Fetal geneticist Dr. Tamar Goldwaser and OB-GYN Dr. Nathan Fox dive into the nuances of carrier screening and why people might hesitate to receive them. Although uncommon, secondary findings are possible and a parent might find something unexpected in their own DNA from a genetic test. Additionally, the results of a genetic test could lead to difficult decisions like whether to consider IVF or freezing your eggs. In this podcast, they discuss the implications and possible next steps to consider for diseases like Fragile X Syndrome, Fabry disease, hemophilia, Gaucher disease, and other genetic mutations.